Glatira 20mg Injection
Prescription Required
Product introduction
Glatira 20mg Injection is a prescription medicine used in the treatment of multiple sclerosis (a disease in which the immune system cells start damaging the insulating covers of the brain and spinal cord cells leading to different types of physical, mental and psychiatric problems).
Glatira 20mg Injection is indicated for the treatment of re-occuring form of multiple sclerosis (abnormal hardening of body tissue)
Glatira 20mg Injection is indicated for the treatment of re-occuring form of multiple sclerosis (abnormal hardening of body tissue)
Uses of Glatira Injection
Benefits of Glatira Injection
In Multiple sclerosis (MS)
Multiple sclerosis (MS) is a disease of the brain and spinal cord in which a person’s own immune system attacks the protective sheath (called myelin) of the nerves. This leads to symptoms such as vision loss, pain, fatigue and improper coordination. Glatira 20mg Injection helps to suppress the body’s immune system, thereby reducing the progression of the disease. It reduces the inflammation of the damaged nerves, prevents further damage and stabilises your immune system. This medicine is given as an injection by a doctor or nurse and should not be self-administered. Follow your doctor’s instructions carefully to get the best results.
Side effects of Glatira Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Glatira
- Rash
- Breathlessness
- Chest pain
- Vasodilation
- Injection site reaction
How to use Glatira Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with Glatira 20mg Injection. Please consult your doctor.
Pregnancy
SAFE IF PRESCRIBED
Glatira 20mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
SAFE IF PRESCRIBED
Glatira 20mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
CONSULT YOUR DOCTOR
It is not known whether Glatira 20mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Glatira 20mg Injection in patients with kidney disease. Please consult your doctor.
Regular monitoring of kidney function tests is advised while you are taking this medicine.
Regular monitoring of kidney function tests is advised while you are taking this medicine.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Glatira 20mg Injection in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Glatira 20mg Injection
₹374.17/Injection
Glatimer 20mg Injection
Natco Pharma Ltd
₹990/injection
165% costlier
Glatrus 20mg Injection
Taj Pharma India Ltd
₹387/injection
3% costlier
Glataxone Injection
Abbott
₹1002.13/injection
168% costlier
Quick tips
- Glatira 20mg Injection helps reduce the number of times you suffer attacks of MS (relapses).
- It is injected into the tissue under the skin (subcutaneous tissue) only. Never inject it into a vein or a muscle.
- A different injection site should be used for each dose.
- Always store your injections in the refrigerator (2°C to 8°C).
- Never use the same syringe more than once. Discard any unused product or waste.
- It may cause symptoms such as flushing, chest pain, shortness of breath, and difficulty breathing that normally go away on their own within half an hour. Inform your doctor immediately if they last longer or become severe.
Fact Box
Chemical Class
Amino Acids, Peptides, Analogues
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Immunomodulator- Multiple sclerosis (Injectable)
Patient concerns
User feedback
Patients taking Glatira 20mg Injection
Once A Day
87%
Once A Week
13%
What are you using Glatira Injection for?
Multiple scle*
100%
*Multiple sclerosis (MS)
How much was the improvement?
Average
44%
Excellent
33%
Poor
22%
What were the side-effects while using Glatira 20mg Injection?
Rash
50%
No Side Effec*
50%
*No Side Effect
How do you take Glatira Injection?
With or witho*
100%
*With or without food
Please rate Glatira 20mg Injection on price
Average
100%
FAQs
What is Glatira 20mg Injection?
Glatira 20mg Injection is an immunomodulatory agent. It works by modifying the body's immune system and thereby preventing the damage to the insulating covers (myelin sheath) and protecting the brain and spinal cord.
What is Glatira 20mg Injection used for?
Glatira 20mg Injection is used for the treatment of multiple sclerosis (disease in which the immune system i.e. the cells responsible for defense in the body and damages the insulating covers (myelin sheath) of the brain and spinal cord cells leading to different types of physical, mental and psychiatric problems) and to reduce the frequency of recurrences of the attacks of multiple sclerosis in ambulatory patients (i.e. who can walk without help) with relapsing, remitting multiple sclerosis characterized by at least two attacks in the past two year period.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 628-29.
- Glatiramer Acetate [FDA Label]. Overland Park, Kansas: TEVA Neuroscience, Inc.; 1996 [revised Jan. 2014]. [Accessed 25 Mar. 2019] (online) Available from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Glatiramer. [Updated 2019 Jun 30]. [Accessed 20 Feb. 2020] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 25 Mar. 2019] (online) Available from:
Marketer details
Name: Cipla Ltd
Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
Country of origin: India
Lab tests offered by us
Related/Popular tests
41 people viewed this recentlyDISCONTINUED
We do not facilitate sale of this product at present